Abstract
3-Substituted quinazoline-2,4(1H,3H)-dione and 2,3-di-substituted quinazolineone derivatives attract considerable interest due to their pharmacological properties. In this paper, we report the synthesis of N-substituted-3-nitrophthalimide derivatives II–III, the reactions of phthalimide III with amines, hydrazines, and amino acid derivatives to synthesise a small library of 3-substituted-5-nitroquinazoline-2,4(1H,3H)-diones IV–XIV and 2,3-di-substituted-6-nitro-quinazolineones XVIII–XIX.
Similar content being viewed by others
References
Connolly, D. J., Cusack, D., O’sullivan, T. P.,& Guiry, P. J. (2005). Synthesis of quinazolinones and quinazolines. Tetrahedron, 61, 10153–10202. DOI: 10.1016/j.tet.2005.07.010.
Fahmy, A. F. M. (2006). Heterocycles as versatile building blocks in different synthetic strategies. ARKIVOC, 2006(vii), 395–415.
Fahmy, A. F. M., Aly, N. F., Nada, A.,& Aly, N. Y. (1977). Phthalimides. I. Base-catalyzed Lossen rearrangement and acid-catalyzed Beckmann rearrangement with N-(arylsulfonyloxy)phthalimides. Bulletin of the Chemical Society of Japan, 50, 2678–2681. DOI: 10.1246/bcsj.50.2678.
Fahmy, A. F. M., Aly, N. F.,& Orabi, M. O. (1978). Phthalimides. III. Aminolysis, hydrazinolysis, pyrolysis, and activation of Grignard reagents on phthalimide derivatives. Bulletin of the Chemical Society of Japan, 51, 2148–2152. DOI: 10.1246/bcsj.51.2148.
Fahmy, A. F., Youssef, M. S. K., Halim M. S. A., Hassan, M. A., & Sauer, J. (1986). Novel synthesis of pyridopyrimidine diones. Heterocycles, 24, 2201–2213. DOI: 10.3987/r-198608-2201.
Farouk, M. (2009). Bioactive heterocyclic’s based nanotechnology. Synthesis and in-vitro evaluation of new 3-substituted quinazolinediones. In First International Conference for NanoTechnology Industries (ICNI 2009), April 5–7, 2009. Riyadh, Saudi Arabia: King Saud University.
Farouk, M., Alrokayan, S. A., Imran, A., & Abu-Salah, K. M. (2012). One-pot synthesis and luminescent spectra of 3-allyl substituted quinazoline-2,4-dione derivatives as allyl capping agents. Chemical Papers, 66, 75–78. DOI: 10.2478/s11696011-0094-2.
Fieser, L. F., & Fieser, M. (1967). Reagents for organic synthesis (pp. 485–486). New York, NY, USA: Wiley.
Furniss, B. S., Hannaford, A. J., Smith, P. W. G., Tatchell, A. R., & Vogel, A. I. (1989). Vogel’s textbook of practical organic chemistry (5th ed.). Harlow, UK: Pearson Education Limited.
Gütschow, M. (1999). One-pot reactions of N-(mesyloxy)phthalimides with secondary amines to 2-ureidobenzamides, 2-ureidobenzoic acids, ethyl 2-ureidobenzoates, or isatoic anhydrides. The Journal of Organic Chemistry, 64, 5109–5115. DOI: 10.1021/jo9900634.
Huang, C., Meng, X., Cui, J., & Li, Z. (2009). Synthesis of 3-N-sugar-substituted-2,4(1H,3H)-quinazolinediones as anti-angiogenesis agents. Molecules, 14, 2447–2457. DOI: 10.3390/molecules14072447.
Jain, K. S., Bariwal, J. B., Kathiravan, M. K., Phoujdar, M. S., Sahne, R. S., Chauhan, B. S., Shah, A. K., & Yadav, M. R. (2008). Recent advances in selective α 1-adrenoreceptor antagonists as antihypertensive agents. Bioorganic & Medicinal Chemistry, 16, 4759–4800. DOI: 10.1016/j.bmc.2008.02.091.
Kakuta, H., Koiso, Y., Nagasawa, K., & Hashimoto, Y. (2003a). Fluorescent bioprobes for visualization of puromycin-sensitive aminopeptidase in living cells. Bioorganic & Medical Chemistry Letters, 13, 83–86. DOI: 10.1016/s0960894x(02)00845-4.
Kakuta, H., Tanatani, A., Nagasawa, K., & Hashimoto, Y. (2003b). Specific nonpeptide inhibitors of puromycin-sensitive aminopeptidase with a 2,4(1H,3H)-quinazolinedione skeletone. Chemical and Pharmaceutical Bulletin, 51, 1273–1282. DOI: 10.1248/cpb.51.1273.
Katritzky, A. R., & Rees, C. W. (1984). Comprehensive heterocyclic chemistry: The structure, reactions, synthesis and uses of heterocyclic compounds (Vol. 3). Oxford, UK: Pergamon Press.
Kirincich, S. J., Xiang, J., Green, N., Tam, S., Yang, H. Y., Shim, J., Shen, M. W. H., Clark, J. D., & McKew, J. C. (2009). Benzhydrylquinazolinediones: Novel cytosolic phospholipase A2 α ginhibitors with improved physicochemical properties. Bioorganic & Medicinal Chemistry, 17, 4383–4405. DOI: 10.1016/j.bmc.2009.05.027.
Kerrigan, J. E., Walters, M. C., Forrester, K. J., Crowder, J. B., & Christopher, L. J. (2000). 6-Acylamino-2-[(alkylsulfonyl)oxy]-1H-isoindole-1,3-dione mechanism-based inhibitors of human leukocyte elastase. Bioorganic & Medicinal Chemistry Letters, 10, 27–30. DOI: 10.1016/s0960894x(99)00588-0.
Koay, N., & Campeau, L. C. (2011). Efficient preparation of 3-substituted quinazolinediones directly from anthranilic acids and isocyanates. Journal of Heterocyclic Chemistry, 48, 473–478. DOI: 10.1002/jhet.551.
Koller, M., Lingenhoehl, K., Schmutz, M., Vranesic, I. T., Kallen, J., Auberson, Y. P., Carcache, D. A., Mattes, H., Ofner, S., Orain, D., & Urwyler, S. (2011). Quinazolinedione sulfonamides: A novel class of competitive AMPA receptor antagonists with oral activity. Bioorganic & Medicinal Chemistry Letters, 21, 3385–3361. DOI: 10.1016/j.bmcl.2011. 04.017.
Li, J., Chen, X., Shi, D., Ma, S., Li, Zhang, Q., & Tang, J. (2009). A new and facile synthesis of quinazoline-2,4(1H,3H)-diones. Organic Letters, 11, 1193–1196. DOI: 10.1021/ol900093h.
Martyn, D. C., Moore, M. J., & Abell, A. D. (1999). Succinimide and saccharin-based enzyme-activated inhibitors of serine proteases. Current Pharmaceutical Design, 5, 405–416.
Neumann, U., & Gütschow, M. (1994). N-(Sulfonyloxy)phthalimides and analogs are potent inactivators of serine proteases. Journal of Biological Chemistry, 269, 21561–21567.
Orain, D., Ofner, S., Koller, M., Carcache, D. A., Froestl, W., Allgeier, H., Rasetti, V., Nozulak, J., Mattes, H., Soldermann, N., Floersheim, P., Desrayaud, S., Kallen, J., Lingenhoehl, K., & Urwyler, S. (2012). 6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonists. Bioorganic & Medicinal Chemistry Letters, 22, 996–999. DOI: 10.1016/j.bmcl.2011.12.009.
Perrin, D. D., & Armarego, W. L. F. (1988). Purification of laboratory chemicals (3rd ed.). Oxford, UK: Pergamon Press.
Petrov, J. S., & Andreev, G. N. (2005). Synthesis of 2,4(1H,3H)-quinazolinedione and 3-substituted 2,4(1H,3H)-quianzolinediones. Organic Preparations and Procedures International: The New Journal for Organic Synthesis, 37, 560–565. DOI: 10.1080/00304940509354986.
Rivero, I. A., Espinoza, K., & Somanathan, R. (2004). Syntheses of quinazoline-2,4-dione alkaloids and analogues from Mexican Zanthoxylum species. Molecules, 9, 609–616. DOI: 10.3390/90700609.
Rivero, I. A., Guerrero, L., Espinoza, K. A., Meza, M. C., & Rodríguez, J. R. (2009). Alkylation of 2,4-(1H,3H)-quinazolinediones with dialkyl carbonates under microwave irradiations. Molecules, 14, 1860–1868. DOI: 10.3390/molecules14051860.
Sheradsky, T., & Itzhak, N. (1986). Reaction of carbanions with N-tosyloxyphthalimide. Formation of 3, 3-disubstituted quinoline-2, 4-diones. Journal of the Chemical Society, Perkin Transactions, 1986, 13–16. DOI: 10.1039/p19860000013.
Shiau, C. Y., Chern, J. W., Liu, K. C., Chan, C. H., Yen, M. H., Cheng, M. C., & Wang, Y. (1990). Studies on quinazolinones. 2. Synthesis of 2-(4-benzylpiperazin-1-ylmethyl)-2,3-dihydro-5H-oxazolo[2,3-6]quinazolin-5-one and -2,3-dihydro-5H-thiazolo[2,3-b]quinazolin-5-one. Journal of Heterocyclic Chemistry, 27, 1467–1472. DOI: 10.1002/jhet.5570270552.
Vagnoni, L. M., Gronostaj, M., & Kerrigan, J. E. (2001). 6-Acylamino-2-(ethylsulfonyl)oxy]-1H-isoindole-1,3-diones mechanism-based inhibitors of human leukocyte elastase and cathepsin G: effect of chirality in the 6-acylamino substituent on inhibitory potency and selectivity. Bioorganic & Medicinal Chemistry, 9, 637–645. DOI: 10.1016/s09680896(00)00281-9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Farouk, M., Alrokayan, S.A., Imran, A. et al. Facile synthesis of 3-substituted quinazoline-2,4-dione and 2,3-di-substituted quinazolinone derivatives. Chem. Pap. 67, 229–235 (2013). https://doi.org/10.2478/s11696-012-0266-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11696-012-0266-8